Groowe Groowe / Newsroom / ABSI
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABSI News

Absci Corporation Common Stock

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery

businesswire.com
HYFT ABSI

Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight

globenewswire.com
RAPT SANG INCY ABBV ARCT AMGN CHKP PFE LLY SCLX SNY UCB BIIB NVS VTRS BMY ABSI ALEC GSK IONS CLNN ANNX MED GAM VRTX EXC BLRX

Form 8-K

sec.gov
ABSI

Absci to Participate in Upcoming Investor Conferences

globenewswire.com
ABSI

Masitinib Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

globenewswire.com
ABSI

Form 8-K

sec.gov
ABSI

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

globenewswire.com
ABSI

PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
AZN MRK JNJ PFE ABBV GSK ALLR SNY CURI ORIC EXEL ABSI LLY TLX FPH BMY SNX XNCR ZENA ARVN MGNX DASH VERU GILD EVGN GEN AMGN MIR RXRX BG MTX BIO

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
ABSI

Pet Cancer Therapeutics Research Report 2026: $720 Mn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
LNTH ABSI ELAN ZTS